BARTOLOZZI ALESSANDRA has a total of 13 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are EHRREHJ BIOFARMA INK, SANTHERA PHARMACEUTICALS CH and MERCK FROSST CANADA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Bartolozzi Alessandra | 13 |
#2 | Riether Doris | 11 |
#3 | Wu Lifen | 9 |
#4 | Zindell Renee M | 7 |
#5 | Chen Zhidong | 5 |
#6 | Tye Heather | 5 |
#7 | Hickey Eugene Richard | 5 |
#8 | Loke Pui Leng | 5 |
#9 | Huber John D | 4 |
#10 | Ermann Monika | 4 |
Publication | Filing date | Title |
---|---|---|
US2012316173A1 | Compounds which modulate the CB2 receptor | |
US2011136869A1 | Compounds which selectively modulate the CB2 receptor | |
WO2010036631A2 | Sulfonyl compounds which selectively modulate the cb2 receptor |